C4X Discovery Holdings (C4XD) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Apr 2024 07:00 AM
RNS
Cancellation - C4X Discovery Holdings plc
25 Apr 2024 07:00 AM
RNS
Last day of dealings and update on cancellation
23 Apr 2024 03:35 PM
RNS
Holding(s) in Company
19 Apr 2024 06:00 PM
RNS
C4X Discovery Holdings
15 Apr 2024 12:37 PM
RNS
Result of General Meeting
09 Apr 2024 10:58 AM
RNS
Director/PDMR Share Purchases
05 Apr 2024 05:09 PM
RNS
Holding(s) in Company
27 Mar 2024 07:00 AM
RNS
Proposed Voluntary Delisting
27 Mar 2024 07:00 AM
RNS
Interim results
23 Jan 2024 01:57 PM
RNS
Result of AGM
18 Jan 2024 07:00 AM
RNS
Board Update
04 Jan 2024 02:45 PM
RNS
Holding(s) in Company
03 Jan 2024 07:00 AM
RNS
AstraZeneca $11m milestone payment to C4XD
18 Dec 2023 03:31 PM
RNS
Posting of 2023 Annual Report and Notice of AGM
14 Dec 2023 07:00 AM
RNS
Full Year Results
07 Dec 2023 07:00 AM
RNS
Notice of Results
05 Oct 2023 02:35 PM
RNS
Holding(s) in Company
05 Oct 2023 02:35 PM
RNS
Holding(s) in Company
02 Oct 2023 12:36 PM
RNS
Block listing Interim Review
29 Sep 2023 11:14 AM
RNS
Grant of Options and Directors Dealing
28 Sep 2023 03:52 PM
RNS
Holding(s) in Company
01 Sep 2023 07:00 AM
RNS
Total Voting Rights
18 Aug 2023 12:45 PM
RNS
Exercise of Options, Issue of Equity and TVR
01 Aug 2023 07:00 AM
RNS
Divestment of Orexin-1 to Indivior for £15.95m
20 Jun 2023 07:00 AM
RNS
C4X Discovery Holdings plc: Board Change
01 Jun 2023 07:00 AM
RNS
MALT-1 Inhibitor Programme Update
26 Apr 2023 07:00 AM
RNS
Half Year Results
19 Apr 2023 07:00 AM
RNS
Notice of Results
08 Mar 2023 02:49 PM
RNS
Block Listing Interim Review
22 Feb 2023 07:00 AM
RNS
C4XD and Garvan Institute collaboration
24 Jan 2023 11:47 AM
RNS
Result of AGM
19 Jan 2023 07:00 AM
RNS
MALT-1 Inhibitor Programme Update
10 Jan 2023 07:00 AM
RNS
Nick Ray Appointed as Chief Scientific Officer
19 Dec 2022 04:52 PM
RNS
Posting of 2022 Annual Report and Notice of AGM
15 Dec 2022 07:00 AM
RNS
Full Year Results
28 Nov 2022 02:30 PM
EQS
C4X Discovery signs potential $402mln deal
28 Nov 2022 09:00 AM
RNS
Notice of Final Results
28 Nov 2022 07:00 AM
RNS
C4XD Agreement with AstraZeneca
01 Nov 2022 02:03 PM
RNS
Exercise of Options, Issue of Equity and TVR
20 Oct 2022 07:00 AM
RNS
C4XD and HitGen to collaborate in inflammation
04 Oct 2022 02:56 PM
RNS
Holding(s) in Company
22 Sep 2022 04:40 PM
RNS
Second Price Monitoring Extn
22 Sep 2022 04:35 PM
RNS
Price Monitoring Extension
31 Aug 2022 11:10 AM
RNS
Holding(s) in Company
17 Aug 2022 04:06 PM
RNS
Holding(s) in Company
17 Aug 2022 03:43 PM
RNS
Holding(s) in Company
16 Aug 2022 02:17 PM
RNS
Holding(s) in Company
11 Aug 2022 12:43 PM
RNS
Result of Placing to Raise £5.7 million
11 Aug 2022 07:00 AM
RNS
Proposed Placing to Raise Up To £5.7 million
02 Aug 2022 07:00 AM
RNS
Business Update
UK 100

Latest directors dealings